HeraMED Limited (HMD.AX)
AUD 0.02
(0.0%)
AUD 0.02
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -5.71 Million | -3.69 Million | -4.3 Million | -4.03 Million | -3.92 Million | -1.76 Million |
| Net Income | -6.78 Million | -7.04 Million | -7.6 Million | -4.87 Million | -4.5 Million | -3.76 Million |
| Depreciation & Amortization | 664.49 Thousand | 517.01 Thousand | 361.99 Thousand | 375.74 Thousand | 349.51 Thousand | 295.16 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 35.2 Thousand | 679.81 Thousand | 554.79 Thousand | 254.42 Thousand | 258.46 Thousand | - |
| Change in working capital | 100.55 Thousand | -411.64 Thousand | 222.25 Thousand | 75.32 Thousand | 7386.24 | -197.23 Thousand |
| Other non-cash items | 1.52 Million | 3.24 Million | 2.71 Million | 391.09 Thousand | 221.59 Thousand | 1.9 Million |
| Investing Cash Flow | -2100.14 | -996.46 Thousand | -113.81 Thousand | -97.77 Thousand | -298.19 Thousand | -173.67 Thousand |
| Investments in PPE | -2100.14 | -996.46 Thousand | -113.81 Thousand | -97.77 Thousand | -298.19 Thousand | -177.93 Thousand |
| Acquisitions | - | - | - | - | - | 5714.76 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -1 Million | -91.74 Thousand | -62.63 Thousand | -200.74 Thousand | -1447.76 |
| Financing Cash Flow | 3.04 Million | 3.66 Million | 6.5 Million | 3.65 Million | 1.18 Million | 5.96 Million |
| Debt repayment | -148.43 Thousand | -151.15 Thousand | -2.4 Million | -136.62 Thousand | -115.84 Thousand | -151.78 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 3.19 Million | 3.81 Million | 4.25 Million | 3.8 Million | 1.31 Million | 4.48 Million |
| Other Financing Activities | -101.17 Thousand | -148.43 Thousand | 4.65 Million | -153.01 Thousand | -132.69 Thousand | 1.62 Million |
| Accounts receivables | -133.8 Thousand | -18.43 Thousand | -11.19 Thousand | 30.28 Thousand | -111.4 Thousand | -217.48 Thousand |
| Accounts payables | 387.94 Thousand | -190.8 Thousand | 259.05 Thousand | 61.28 Thousand | -20.39 Thousand | 58.86 Thousand |
| Inventory | -153.58 Thousand | -202.39 Thousand | -25.6 Thousand | -16.24 Thousand | 67.94 Thousand | -55.9 Thousand |
| Other working capital | -1.00 | -2.00 | -1.00 | - | 71.24 Thousand | 17.29 Thousand |
| Cash at beginning of period | 3.85 Million | 4.89 Million | 2.46 Million | 2.91 Million | 5.72 Million | 45.6 Thousand |
| Cash at end of period | 1.06 Million | 3.85 Million | 4.89 Million | 2.46 Million | 2.91 Million | 4.03 Million |
| Capital Expenditure | -2100.14 | -996.46 Thousand | -113.81 Thousand | -97.77 Thousand | -298.19 Thousand | -177.93 Thousand |
| Effect of forex changes on cash | -115.47 Thousand | -230.05 Thousand | 88.71 Thousand | 188.58 Thousand | 122.01 Thousand | -36.4 Thousand |
| Net cash flow / Change in cash | -2.79 Million | -1.03 Million | 2.42 Million | -442.66 Thousand | -2.81 Million | 3.98 Million |
| Free Cash Flow | -5.72 Million | -4.68 Million | -4.41 Million | -4.13 Million | -4.22 Million | -1.94 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.21 Million | -6.78 Million | -3.54 Million | -3.23 Million | -7.04 Million | -2.57 Million |
| Depreciation & Amortization | 175.86 Thousand | 664.49 Thousand | 357.66 Thousand | 307.45 Thousand | 517.01 Thousand | 295.03 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 345.03 Thousand | 35.2 Thousand | -98.71 Thousand | 137.04 Thousand | 679.81 Thousand | 218.98 Thousand |
| Change in working capital | - | 100.55 Thousand | -149.57 Thousand | - | -411.64 Thousand | -206.09 Thousand |
| Other non-cash items | -4515.00 | 1.52 Million | 616.2 Thousand | 1.01 Million | 3.24 Million | 1.33 Million |
| Investing Cash Flow | -58.77 Thousand | -2100.14 | -654.75 | -1481.75 | -996.46 Thousand | -295.64 Thousand |
| Investments in PPE | -58.77 Thousand | -2100.14 | -654.75 | -1481.75 | -996.46 Thousand | -295.64 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | -1 Million | -271.95 Thousand |
| Financing Cash Flow | 3.08 Million | 3.04 Million | 3.09 Million | - | 3.66 Million | 3.64 Million |
| Debt repayment | -2.32 Million | -148.43 Thousand | - | - | -151.15 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 3.16 Million | 3.19 Million | 3.25 Million | - | 3.81 Million | 3.79 Million |
| Other Financing Activities | 763.16 Thousand | -101.17 Thousand | 2.96 Million | - | -148.43 Thousand | 3.57 Million |
| Accounts receivables | - | -133.8 Thousand | - | - | -18.43 Thousand | - |
| Accounts payables | - | 387.94 Thousand | - | - | -190.8 Thousand | - |
| Inventory | - | -153.58 Thousand | -149.57 Thousand | - | -202.39 Thousand | -206.09 Thousand |
| Other working capital | - | -1.00 | - | - | -2.00 | - |
| Cash at beginning of period | 1.06 Million | 3.85 Million | 1.23 Million | 3.85 Million | 4.89 Million | 2.7 Million |
| Cash at end of period | 1.4 Million | 1.06 Million | 1.06 Million | 1.23 Million | 3.85 Million | 3.85 Million |
| Capital Expenditure | -58.77 Thousand | -2100.14 | -654.75 | -1481.75 | -996.46 Thousand | -295.64 Thousand |
| Effect of forex changes on cash | 11.13 Thousand | -115.47 Thousand | -49.62 Thousand | -122.58 Thousand | -230.05 Thousand | -881.9 Thousand |
| Net cash flow / Change in cash | 345.49 Thousand | -2.79 Million | -178.92 Thousand | -2.61 Million | -1.03 Million | 1.15 Million |
| Free Cash Flow | -2.75 Million | -5.72 Million | -3.28 Million | -2.53 Million | -4.68 Million | -1.82 Million |
IS3
ROST
300135
300399
002653
HIQ